1. Home
  2. DTIL vs FGB Comparison

DTIL vs FGB Comparison

Compare DTIL & FGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DTIL
  • FGB
  • Stock Information
  • Founded
  • DTIL 2006
  • FGB 2007
  • Country
  • DTIL United States
  • FGB United States
  • Employees
  • DTIL N/A
  • FGB N/A
  • Industry
  • DTIL Biotechnology: Pharmaceutical Preparations
  • FGB Finance/Investors Services
  • Sector
  • DTIL Health Care
  • FGB Finance
  • Exchange
  • DTIL Nasdaq
  • FGB Nasdaq
  • Market Cap
  • DTIL 51.6M
  • FGB 57.5M
  • IPO Year
  • DTIL 2019
  • FGB N/A
  • Fundamental
  • Price
  • DTIL $4.79
  • FGB $4.11
  • Analyst Decision
  • DTIL Strong Buy
  • FGB
  • Analyst Count
  • DTIL 2
  • FGB 0
  • Target Price
  • DTIL $47.00
  • FGB N/A
  • AVG Volume (30 Days)
  • DTIL 85.2K
  • FGB 53.0K
  • Earning Date
  • DTIL 07-31-2025
  • FGB 01-01-0001
  • Dividend Yield
  • DTIL N/A
  • FGB 8.92%
  • EPS Growth
  • DTIL N/A
  • FGB N/A
  • EPS
  • DTIL N/A
  • FGB N/A
  • Revenue
  • DTIL $51,141,000.00
  • FGB N/A
  • Revenue This Year
  • DTIL N/A
  • FGB N/A
  • Revenue Next Year
  • DTIL $30.20
  • FGB N/A
  • P/E Ratio
  • DTIL N/A
  • FGB N/A
  • Revenue Growth
  • DTIL N/A
  • FGB N/A
  • 52 Week Low
  • DTIL $3.61
  • FGB $2.85
  • 52 Week High
  • DTIL $11.09
  • FGB $3.74
  • Technical
  • Relative Strength Index (RSI)
  • DTIL 44.86
  • FGB 55.64
  • Support Level
  • DTIL $4.20
  • FGB $3.98
  • Resistance Level
  • DTIL $5.29
  • FGB $4.17
  • Average True Range (ATR)
  • DTIL 0.36
  • FGB 0.06
  • MACD
  • DTIL -0.03
  • FGB -0.00
  • Stochastic Oscillator
  • DTIL 36.88
  • FGB 50.00

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.

About FGB First Trust Specialty Finance and Financial Opportunities Fund

First Trust Specialty Fnc & Fncl Oppor is a United States-based closed-end management investment company. The Fund's primary investment objective is to seek a high level of current income. It seeks a positive total return as a secondary objective. The Fund seeks to achieve its investment objectives by investing at least 80% of its Managed Assets in a portfolio of securities of specialty finance and other financial companies.

Share on Social Networks: